1Greenhouqh A,Premkumar M,Patel D. Ventilatory strategies for the extremely premature infant [ J ]. Paediatr Anaesth, 2008,18 ( 5 ) : 371 -377.
2Schmidt B, Roberts R, Millar D, et al. Evidence - Based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants [ J ]. Neonatology ,2008,93 ( 4 ) : 284 - 287.
4Lavoie PM, Dube MP. Genetics of bronchopulmonary dysplasia in the age ofgenomics[J]. Curr Opin Pediatr,2010,22:134-138.
5Bhandari A, Bhandari V. Pitfalls, problems and progress in bronchopulmonary dysplasia[ J]. Pediatrics ,2009,123 : 1562 - 1573.
6Thomas W,Speer CP. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia What is the evidence? [ J]. Neonatology,2008,94 ( 3 ) : 150 - 159.
7Schmidt B,Roberts RS, Davis P,et al. Caffeine therapy for apnea of prematurity[ J]. N Engl J Med ,2006,354:2112 - 2121.
8Davis PG,Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups[ J]. J Pediatr,2010, 156:382 - 387.
9Sweet DG,Carnielli V, Greisen G,et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm Infants - 2010 update [ J ]. Neonatology ,2010,97:402 - 417.
10Gortner L, Misselwitz B, Milligan D, et al. Rates of bronchopulmonary dysplasia in very preterm neonates in europe:results from the MOSAIC cohor[J]. Neonatology,2010,99(2) :112 - 117.
2Pansieri C, Pandolfini C, Elie V, et al. Ureaplasma, bron- chopulmonary dysplasia, and azithromycin in European neo- natal intensive care units : a survey [ J ]. Sei Rep, 2014,4 : 4076.
3Jobe AH, Bancalari E. Bronchopulmonary dysplasia [ J ]. Am J Respir Crit Care Med, 2001,163(7) :1723-1729.
4Lex WD, Richardc AE, Henry LH. Dexamethasone treatment in the first week of life for prewenting bronchopulmonary dys- plasia in preterm infants : A system review[ J]. Neonatology, 2010,98(3) :217-224.
5Watterberg KL. Policy statement-postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia [ J ]. Pediatrics, 2010,126(4) :800-808.
6Paananen R, Husa AK, Vuolteenaho R, et al. Blood cyto- kines during the perinatal period in very preterm infants: re- lationship of inflammatory response and bronchopulmonary dysplasia [J]. J Pediatr, 2009,154 ( 1 ) : 39-43.
7Halliday HL,Ehrenkranz RA, Doyle LW. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants [ J ]. Cochrane Database Syst Rev, 2009,1 : D 1145.
8Halliday HL, Ehrenkranz RA, Doyle LW. Early ( < 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants [J].[J].Cochrane Database Syst Rev, 2009, 1 :D1146.
9Onland W, Offringa M, van Kaam A. Late ( >/= 7 days ) in- halation corticosteroids to reduce bronchopulmonary dyspla- sia in preterm infants [ J ]. Cochrane Database Syst Rev, 2012,4 : D2311.
